Dr. David Spiegel, to speak on the role of Hypnosis and Group Support in Medical Care

May 06, 2003

WHAT: On Tuesday, May 6, the National Center for Complementary and Alternative Medicine (NCCAM) will host the third lecture in its series Distinguished Lectures in the Science of Complementary and Alternative Medicine.

WHEN: The lecture will take place from 12:00 noon to 1:00 p.m. in Masur Auditorium at the Clinical Center (Building 10) on the NIH campus in Bethesda, Maryland. The event is free and open to the public and will be videocast live at http://videocast.nih.gov.

WHY: The lecture, entitled "Hypnosis and Group Support in Medical Care: Altering Perception and Reality," will be presented by David Spiegel, M.D., professor and associate chair of the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.

ABOUT THE SPEAKER:

A leader in the field of psychosomatic research treatment and development, Dr. Spiegel's particular interest is the field of psychoneuroendocrinology/oncology, examining the relationship of stress and support to cancer survival time. He has also had a long interest in the use of hypnosis and treatment for medical symptoms and treatment effects. In 1978, he and his father, Herbert Spiegel, M.D., coauthored Trance and Treatment, which has since become a standard textbook on the clinical uses of hypnosis. Dr. Spiegel's book with Dr. Catherine Classen, Group Therapy for Cancer Patients, chronicles his experience helping patients with advanced cancers cope with their illness.

Since beginning research on the effects of support groups for women with metastatic breast cancer in 1976, Dr. Spiegel has since published numerous studies that demonstrate that group psychotherapeutic interventions have positive effects on mood disturbances, coping, and pain. He is the author of a landmark study, "Effect of Psychosocial Treatment of Patients with Metastatic Breast Cancer," published in The Lancet in 1989. This study demonstrated that the application of supportive-expressive group therapy in women with terminal disease not only improved quality of life, but significantly enhanced survival time. Dr. Spiegel's work was featured on the Bill Moyers' Emmy Award-winning special Healing and the Mind.

A member of the editorial boards of 11 leading medical journals, Dr. Spiegel's research is supported by a number of distinguished research and charitable foundations. His current research involves collaborative efforts with investigators in Canada, Norway, Israel, and Australia, as well as a variety of medical/surgical specialists, psychiatrists, and psychologists in the United States.

For reasonable accommodations, please contact Michel Vioemans at 301-402-9686.
-end-
The National Center for Complementary and Alternative Medicine NCCAM) is dedicated to exploring complementary and alternative medical (CAM) practices in the context of rigorous science, training CAM researchers, and disseminating authoritative information to the public and professionals. For additional information, call NCCAM's Clearinghouse toll free at 1-888-644-6226, or visit the NCCAM Web site at http://nccam.nih.gov/news/lectures/upcoming.htm.

NIH/National Institutes of Health

Related Alternative Medicine Articles from Brightsurf:

An alternative to animal experiments
Researchers of the Technical University of Munich (TUM) have cultured so-called intestinal organoids from human intestinal tissue, which is a common byproduct when performing bowel surgery.

Graduates of family medicine residencies are likely to enter and remain in family medicine
This study provides an overview of the characteristics of physicians who completed family medicine residency training from 1994 to 2017.

Survey: Alternative medicine is widespread among people with MS
A new survey of more than 1,000 people with multiple sclerosis finds that an overwhelming majority use complementary and alternative medicine, with many using cannabis.

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

Psoriasis patients turn to alternative medicine when traditional treatments fail
A recent survey from the GW School of Medicine and Health Sciences found patients with psoriasis frequently use complementary or alternative therapies to treat their symptoms when traditional treatments fail.

One-third of cancer patients use complementary and alternative medicine
A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

Lots of patients with cancer, cancer survivors use but don't report complementary/alternative medicine therapies
This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines (CAMS) in addition to or instead of conventional therapies, and how many don't disclose that to their physicians.

A viable alternative to Medicare-for-all? We can and must do better!
Medicare-for-all, a solution that would bring United States healthcare policies more in line with other industrial nations, faces strong opposition and is unlikely to be enacted in the foreseeable future.

Study reveals complementary medicine use remains hidden to conventional medicine providers
Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.

Read More: Alternative Medicine News and Alternative Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.